vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and ZIFF DAVIS, INC. (ZD). Click either name above to swap in a different company.

ZIFF DAVIS, INC. is the larger business by last-quarter revenue ($406.7M vs $359.9M, roughly 1.1× AdvanSix Inc.). ZIFF DAVIS, INC. runs the higher net margin — 0.1% vs -0.8%, a 0.9% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -1.5%). ZIFF DAVIS, INC. produced more free cash flow last quarter ($157.8M vs $36.1M). Over the past eight quarters, ZIFF DAVIS, INC.'s revenue compounded faster (13.7% CAGR vs 3.4%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

Ziff Davis, Inc. is an American digital media and Internet company. Founded in 1927 by William Bernard Ziff Sr. and Bernard George Davis, the company primarily owns technology- and health-oriented media websites, online shopping-related services, Internet connectivity services, gaming and entertainment brands, and cybersecurity and martech tools. Previously, the company was predominantly a publisher of hobbyist magazines.

ASIX vs ZD — Head-to-Head

Bigger by revenue
ZD
ZD
1.1× larger
ZD
$406.7M
$359.9M
ASIX
Growing faster (revenue YoY)
ASIX
ASIX
+10.9% gap
ASIX
9.4%
-1.5%
ZD
Higher net margin
ZD
ZD
0.9% more per $
ZD
0.1%
-0.8%
ASIX
More free cash flow
ZD
ZD
$121.6M more FCF
ZD
$157.8M
$36.1M
ASIX
Faster 2-yr revenue CAGR
ZD
ZD
Annualised
ZD
13.7%
3.4%
ASIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASIX
ASIX
ZD
ZD
Revenue
$359.9M
$406.7M
Net Profit
$-2.8M
$370.0K
Gross Margin
7.6%
85.9%
Operating Margin
-0.7%
21.2%
Net Margin
-0.8%
0.1%
Revenue YoY
9.4%
-1.5%
Net Profit YoY
-892.9%
-99.4%
EPS (diluted)
$-0.11
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
ZD
ZD
Q4 25
$359.9M
$406.7M
Q3 25
$374.5M
$363.7M
Q2 25
$410.0M
$352.2M
Q1 25
$377.8M
$328.6M
Q4 24
$329.1M
$412.8M
Q3 24
$398.2M
$353.6M
Q2 24
$453.5M
$320.8M
Q1 24
$336.8M
$314.5M
Net Profit
ASIX
ASIX
ZD
ZD
Q4 25
$-2.8M
$370.0K
Q3 25
$-2.6M
$-3.6M
Q2 25
$31.4M
$26.3M
Q1 25
$23.3M
$24.2M
Q4 24
$352.0K
$64.1M
Q3 24
$22.3M
$-48.6M
Q2 24
$38.9M
$36.9M
Q1 24
$-17.4M
$10.6M
Gross Margin
ASIX
ASIX
ZD
ZD
Q4 25
7.6%
85.9%
Q3 25
6.8%
85.4%
Q2 25
14.3%
86.1%
Q1 25
14.2%
85.6%
Q4 24
3.4%
87.1%
Q3 24
14.4%
85.5%
Q2 24
17.9%
84.4%
Q1 24
0.9%
85.4%
Operating Margin
ASIX
ASIX
ZD
ZD
Q4 25
-0.7%
21.2%
Q3 25
-0.9%
7.8%
Q2 25
7.7%
9.5%
Q1 25
7.7%
10.7%
Q4 24
-3.9%
19.0%
Q3 24
7.5%
-8.3%
Q2 24
11.5%
8.9%
Q1 24
-7.0%
11.4%
Net Margin
ASIX
ASIX
ZD
ZD
Q4 25
-0.8%
0.1%
Q3 25
-0.7%
-1.0%
Q2 25
7.7%
7.5%
Q1 25
6.2%
7.4%
Q4 24
0.1%
15.5%
Q3 24
5.6%
-13.7%
Q2 24
8.6%
11.5%
Q1 24
-5.2%
3.4%
EPS (diluted)
ASIX
ASIX
ZD
ZD
Q4 25
$-0.11
$0.06
Q3 25
$-0.10
$-0.09
Q2 25
$1.15
$0.62
Q1 25
$0.86
$0.56
Q4 24
$0.02
$1.53
Q3 24
$0.82
$-1.11
Q2 24
$1.43
$0.77
Q1 24
$-0.65
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
ZD
ZD
Cash + ST InvestmentsLiquidity on hand
$19.8M
$607.0M
Total DebtLower is stronger
$866.5M
Stockholders' EquityBook value
$815.2M
$1.8B
Total Assets
$1.7B
$3.7B
Debt / EquityLower = less leverage
0.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
ZD
ZD
Q4 25
$19.8M
$607.0M
Q3 25
$23.7M
$503.4M
Q2 25
$18.4M
$457.3M
Q1 25
$8.3M
$431.0M
Q4 24
$19.6M
$505.9M
Q3 24
$17.3M
$386.1M
Q2 24
$12.1M
$687.2M
Q1 24
$20.6M
$751.2M
Total Debt
ASIX
ASIX
ZD
ZD
Q4 25
$866.5M
Q3 25
Q2 25
Q1 25
Q4 24
$864.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASIX
ASIX
ZD
ZD
Q4 25
$815.2M
$1.8B
Q3 25
$818.2M
$1.8B
Q2 25
$823.7M
$1.8B
Q1 25
$794.4M
$1.8B
Q4 24
$774.6M
$1.8B
Q3 24
$766.4M
$1.8B
Q2 24
$746.6M
$1.9B
Q1 24
$713.2M
$1.9B
Total Assets
ASIX
ASIX
ZD
ZD
Q4 25
$1.7B
$3.7B
Q3 25
$1.7B
$3.5B
Q2 25
$1.6B
$3.5B
Q1 25
$1.6B
$3.5B
Q4 24
$1.6B
$3.7B
Q3 24
$1.5B
$3.4B
Q2 24
$1.5B
$3.7B
Q1 24
$1.5B
$3.7B
Debt / Equity
ASIX
ASIX
ZD
ZD
Q4 25
0.49×
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
ZD
ZD
Operating Cash FlowLast quarter
$63.7M
$191.1M
Free Cash FlowOCF − Capex
$36.1M
$157.8M
FCF MarginFCF / Revenue
10.0%
38.8%
Capex IntensityCapex / Revenue
7.7%
8.2%
Cash ConversionOCF / Net Profit
516.44×
TTM Free Cash FlowTrailing 4 quarters
$6.4M
$287.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
ZD
ZD
Q4 25
$63.7M
$191.1M
Q3 25
$26.6M
$138.3M
Q2 25
$21.1M
$57.1M
Q1 25
$11.4M
$20.6M
Q4 24
$64.2M
$158.2M
Q3 24
$57.3M
$106.0M
Q2 24
$50.2M
$50.6M
Q1 24
$-36.2M
$75.6M
Free Cash Flow
ASIX
ASIX
ZD
ZD
Q4 25
$36.1M
$157.8M
Q3 25
$66.0K
$108.2M
Q2 25
$-7.2M
$26.9M
Q1 25
$-22.6M
$-5.0M
Q4 24
$29.8M
$131.1M
Q3 24
$26.8M
$80.1M
Q2 24
$16.7M
$25.1M
Q1 24
$-71.6M
$47.4M
FCF Margin
ASIX
ASIX
ZD
ZD
Q4 25
10.0%
38.8%
Q3 25
0.0%
29.7%
Q2 25
-1.7%
7.6%
Q1 25
-6.0%
-1.5%
Q4 24
9.1%
31.8%
Q3 24
6.7%
22.7%
Q2 24
3.7%
7.8%
Q1 24
-21.3%
15.1%
Capex Intensity
ASIX
ASIX
ZD
ZD
Q4 25
7.7%
8.2%
Q3 25
7.1%
8.3%
Q2 25
6.9%
8.6%
Q1 25
9.0%
7.8%
Q4 24
10.4%
6.6%
Q3 24
7.7%
7.3%
Q2 24
7.4%
8.0%
Q1 24
10.5%
8.9%
Cash Conversion
ASIX
ASIX
ZD
ZD
Q4 25
516.44×
Q3 25
Q2 25
0.67×
2.17×
Q1 25
0.49×
0.85×
Q4 24
182.29×
2.47×
Q3 24
2.57×
Q2 24
1.29×
1.37×
Q1 24
7.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

ZD
ZD

Health And Wellness$114.8M28%
Technology And Shopping$108.9M27%
Cybersecurity And Martech Segment$70.9M17%
Connectivity$60.3M15%
Gaming And Entertainment$51.7M13%
Subscription And Licensing$2.9M1%

Related Comparisons